Glenmark Pharmaceuticals Limited
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
4/10
|
40.73 | 59.64 | -31.7% | 19.84 | +105.35% |
| P/S |
|
2.2 | 9.32 | -76.43% |
|
|
| P/BV |
|
3.31 | 6.64 | -50.19% |
|
|
| P/FCF |
|
-19.13 | -14.63 | 30.77% |
|
|
| Ev/Ebitda |
|
22.51 | 141.59 | -84.1% |
|
|
| Ev/S |
|
2.16 | 9.59 | -77.47% |
|
|
| Ev/FCF |
|
-21.94 | -85.24 | -74.26% |
|
|
| E/P |
|
-0.0674 | 0.0857 | -178.61% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
3/10
|
9.6 | 5.56 | 72.67% | 14.92 | -35.65% |
| ROE |
|
-17.34 | 10.72 | -261.67% |
|
|
| ROA |
|
-8.9 | 7.64 | -216.58% |
|
|
| ROIC |
|
2.94 | 15.91 | -81.5% |
|
|
| ROS |
|
-12.71 | -4.5 | 182.43% |
|
|
| ROCE |
|
6.47 | 13.08 | -50.53% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
8/10
|
1.09 | 121.74 | -99.11% | 2.35 | -53.85% |
| Nеt Debt/Ebitda |
|
-0.3767 | 121.47 | -100.31% |
|
|
| Debt/Ratio |
|
0.0857 | 0.145 | -40.9% |
|
|
| Debt/Equity |
|
0.2452 | 1.81 | -86.47% |
|
|
| Debt/Net Income |
|
-0.8197 | 5.06 | -116.19% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0.35/10
|
0.1443 | 9.55 | -98.49% | 0.4972 | -70.98% |
| Number of years of dividend growth |
|
0 | 0.7317 | -100% | ||
| DSI |
|
1 | 0.8351 | 19.75% |
|
|
| Average dividend growth |
|
3.33 | -3.25 | -202.58% |
|
|
| Average percentage for 5 years |
|
0.4972 | 14.84 | -96.65% |
|
|
| Average percentage for payments |
|
10.66 | 24.67 | -56.8% |
|
|
| Difference from average difference in sector |
|
-9.41 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
2/10
|
13.62 | 42.49 | -67.95% | ||
| Growth impulse Ebitda in 5 years |
|
-38.97 | 26.93 | -244.71% | ||
| Growth impulse Net Income in 5 years |
|
-293.52 | 77.88 | -476.89% | ||
| Growth impulse FCF in 5 years |
|
-352.43 | -25 | 1309.72% | ||
| Growth impulse EPS in 5 years |
|
-298.57 | -13.73 | 2074.58% |
IP Score
3.84/10
